191 related articles for article (PubMed ID: 24935876)
1. Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.
Ehdaie B; Atoria CL; Lowrance WT; Herr HW; Bochner BH; Donat SM; Dalbagni G; Elkin EB
Urol Oncol; 2014 Aug; 32(6):779-84. PubMed ID: 24935876
[TBL] [Abstract][Full Text] [Related]
2. Adherence to surveillance among patients with superficial bladder cancer.
Schrag D; Hsieh LJ; Rabbani F; Bach PB; Herr H; Begg CB
J Natl Cancer Inst; 2003 Apr; 95(8):588-97. PubMed ID: 12697851
[TBL] [Abstract][Full Text] [Related]
3. General adherence to guideline recommendations on initial diagnosis of bladder cancer in the United States and influencing factors.
Karl A; Adejoro O; Saigal C; Konety B;
Clin Genitourin Cancer; 2014 Aug; 12(4):270-7. PubMed ID: 24332507
[TBL] [Abstract][Full Text] [Related]
4. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
Yafi FA; Aprikian AG; Fradet Y; Chin JL; Izawa J; Rendon R; Estey E; Fairey A; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Saad F; Drachenberg D; Kassouf W
BJU Int; 2012 Nov; 110(9):1317-23. PubMed ID: 22500588
[TBL] [Abstract][Full Text] [Related]
5. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
[TBL] [Abstract][Full Text] [Related]
6. Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program.
Konety BR; Dhawan V; Allareddy V; Joslyn SA
J Urol; 2005 Jun; 173(6):2085-9. PubMed ID: 15879848
[TBL] [Abstract][Full Text] [Related]
7. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
8. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach.
Stewart-Merrill SB; Boorjian SA; Thompson RH; Psutka SP; Cheville JC; Thapa P; Bergstrahl EJ; Tollefson MK; Frank I
Urol Oncol; 2015 Aug; 33(8):339.e1-8. PubMed ID: 26031371
[TBL] [Abstract][Full Text] [Related]
10. Hospital lymph node counts and survival after radical cystectomy.
Hollenbeck BK; Ye Z; Wong SL; Montie JE; Birkmeyer JD
Cancer; 2008 Feb; 112(4):806-12. PubMed ID: 18085612
[TBL] [Abstract][Full Text] [Related]
11. Use of radical cystectomy for patients with invasive bladder cancer.
Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS;
J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716
[TBL] [Abstract][Full Text] [Related]
12. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.
Schrag D; Mitra N; Xu F; Rabbani F; Bach PB; Herr H; Begg CB
Urology; 2005 Jun; 65(6):1118-25. PubMed ID: 15922428
[TBL] [Abstract][Full Text] [Related]
13. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
[TBL] [Abstract][Full Text] [Related]
14. Volume, process of care, and operative mortality for cystectomy for bladder cancer.
Hollenbeck BK; Wei Y; Birkmeyer JD
Urology; 2007 May; 69(5):871-5. PubMed ID: 17482924
[TBL] [Abstract][Full Text] [Related]
15. Volume outcomes of cystectomy--is it the surgeon or the setting?
Morgan TM; Barocas DA; Keegan KA; Cookson MS; Chang SS; Ni S; Clark PE; Smith JA; Penson DF
J Urol; 2012 Dec; 188(6):2139-44. PubMed ID: 23083864
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
Konety BR; Joslyn SA
J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
[TBL] [Abstract][Full Text] [Related]
17. Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use?
Hollenbeck BK; Taub DA; Dunn RL; Wei JT
J Urol; 2005 Sep; 174(3):1050-4; discussion 1054. PubMed ID: 16094056
[TBL] [Abstract][Full Text] [Related]
18. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
SÅ‚ojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
19. Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey.
Winters BR; Wright JL; Holt SK; Dash A; Gore JL; Schade GR
J Urol; 2018 Mar; 199(3):669-675. PubMed ID: 28882404
[TBL] [Abstract][Full Text] [Related]
20. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
